Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Ex vivo pulsed dendritic cell vaccination against cancer
/in Dendritic Cells, International Publications /von 2020-05-04 / Acta Pharmacol. Sin. 2020 May;Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2020-04-22 / Curr. Opin. Biotechnol. 2020 Apr;65:190-196Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
/in Dendritic Cells, International Publications /von 2020-04-07 / Clin Transl Oncol 2020 Apr;Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells
/in Dendritic Cells, International Publications /von 2020-04-01 / J Immunother Cancer 2020 Apr;8(1)A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
/in Hyperthermia, International Publications, NSCLC /von 2020-03-17 / J Adv Res 2020 Jul;24:175-182Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-03-16 / Cancer Cell 2020 Mar;37(3):289-307.e9Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
/in Dendritic Cells, Hyperthermia, International Publications /von 2020-03-12 / Pharmaceutics 2020 Mar;12(3)Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
/in Hyperthermia, International Publications /von 2020-03-10 / Front Oncol 2020;10:254New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2020-03-06 / Biomedicines 2020 Mar;8(3)Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
/in Dendritic Cells, International Publications /von 2020-03-05 / Cancers (Basel) 2020 Mar;12(3)Dendritic cell vaccine for the effective immunotherapy of breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-03-04 / Biomed. Pharmacother. 2020 Jun;126:110046Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
/in Acute Leukemia, Dendritic Cells, International Publications /von 2020-03-03 / Clin Transl Immunology 2020;9(3):e1117Photodynamic Therapy-Based Dendritic Cell Vaccination Suited to Treat Peritoneal Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2020-02-27 / Cancers (Basel) 2020 Feb;12(3)Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells
/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2020-02-26 / J. Cell. Mol. Med. 2020 Apr;24(7):4286-4297Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
/in International Publications, Newcastle Disease Virus /von 2020-02-22 / Cancer Immunol. Immunother. 2020 Feb;Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2020-02-07 / J Clin Oncol 38, 2020 (suppl 5; abstr 63)Interferon-α2b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines
/in Dendritic Cells, Malignant Melanoma /von 2020-01-31 / Biomed. Pharmacother. 2020 May;125:109966Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2020-01-24 / Cancer Immunol. Immunother. 2020 Mar;69(3):477-488Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
/in Dendritic Cells, Glioblastoma, International Publications /von 2020-01-16 / NPJ Vaccines 2020;5:5Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-01-01 / Cytotherapy 2020 Jan;22(1):6-15